Sanofi teams up with basketball star to promote OTC Nasacort; Novartis mistakenly touts Zykadia approval;

> Sanofi ($SNY) has brought on former WNBA star and coach Nancy Lieberman to help promote its OTC version of allergy med Nasacort, a move it says will help allergy sufferers "put the full 'cort press" on symptoms. Release

> Novartis ($NVS) accidentally sent out a mass email announcing the FDA approval of lung cancer drug Zykadia--a drug the agency has not actually approved yet. News

> Pfizer's ($PFE) consumer healthcare unit has teamed up with actor Josh Duhamel for its Advil Relief in Action campaign, which features a Mobile Relief Center tour making about 100 stops across the country. More

> Keryx Biopharmaceuticals ($KERX) has appointed three executives to strategic roles in preparation for the anticipated launch of Zerenex. Release

> CDM Group has named Josh Prince as president of its portfolio of healthcare agencies. News (reg. req.)

> Insurers, now unable to turn away diabetics under the Affordable Care Act, are checking in with patients to ensure adherence to their diet plans and medications. Report

> Sanofi ($SNY) has launched a £50,000 U.K. patient group fund, which supports organizations that promote patient interests. More

> Teva ($TEVA) has launched a generic of Sunovion's insomnia treatment Lunesta. Report

And Finally... Pfizer ($PFE) has reminded the creator of celebrity-commissioned Viagra-laced ice cream that its erectile dysfunction treatment should be prescribed by a healthcare professional and used according to its labeling. More

Suggested Articles

Pfizer and Astellas are chasing a new nod for prostate cancer drug Xtandi, and thanks to the FDA, they might not have to wait that long.

As AZ and FibroGen have yet to submit the novel anemia drug to the U.S. regulators, national reimbursement talks are already underway in China.

Health and Human Services, hoping to resurrect a rule that would force drug prices into TV ads, appealed a judge's decision that blocked it.